# Bexarotene With Narrow-Band UVB for Psoriasis

> **NCT00151008** · PHASE2 · COMPLETED · sponsor: **University of Medicine and Dentistry of New Jersey** · enrollment: 35 (—)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Bexarotene/NBUVB vs placebo NBUVB

## Key facts

- **NCT ID:** NCT00151008
- **Lead sponsor:** University of Medicine and Dentistry of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 35 (—)
- **Last updated:** 2008-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00151008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00151008, "Bexarotene With Narrow-Band UVB for Psoriasis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00151008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*